期刊文献+

球后注射糖皮质激素治疗甲状腺相关眼病的Meta分析 被引量:6

Treatment for Thyroid-associated Ophthalmopathy with Retrobular Injection of Glucocorticoid:A Meta-analysis
下载PDF
导出
摘要 目的系统评价球后注射糖皮质激素治疗甲状腺相关眼病的临床效果。方法计算机检索CochraneLibrary(2010年第1期)、EBMReviews、PubMed和中国生物医学文献数据库。检索时间为建库至2010年4月。全面收集球后注射糖皮质激素治疗甲状腺相关眼病的随机对照试验(RCT),评价纳入研究质量,提取有效数据,采用RevMan4.2.8软件进行Meta分析。结果共纳入7个RCT,共398例患者。按测量指标和干预措施进行亚组分析。Meta分析结果显示,总有效率比较,球后注射优于空白对照组,差异有统计学意义[RR=1.35,95%CI(1.10,1.65),P=0.004],球后注射与口服激素间差异无统计学意义[RR=1.15,95%CI(0.93,1.42),P=0.20],球后注射组与球后注射联合放疗组差异有统计学意义[RR=0.85,95%CI(0.72,1.00),P=0.04]。球后注射组3例患者出现眶内出血和2例患者出现软组织加重的局部并发症,未出现体重加重及柯兴综合征等全身并发症。结论现有临床研究证据显示,球后注射糖皮质激素是治疗甲状腺相关眼病的有效治疗方案,可避免全身用药的副作用。联合球后放疗可提高疗效。 Objective To evaluate the efficacy of treatment of thyroid-associated ophthalmopathy with retrobular injection of glucocorticoid.Methods We searched The Cochrane Library(Issue 1,2010),EBM Reviews,PubMed and CBMdisc to collect randomized controlled trials(RCTs) of retrobular injection of glucocorticoid for thyroid-associated ophthalmopathy.The quality of the included trials was assessed and meta-analyses were conducted by RevMan 4.2.8 software.We conducted subgroup analyses based on the outcome measures and intervention.Results A total of 7 RCTs were identified.There were significant differences between retrobular injection of glucocorticoid and blank in the effective rate(RR=1.35,95%CI 1.10 to 1.65,P=0.004).There were no signif icant differences between retrobular injection of glucocorticoid and oral glucocorticoid in the effective rate(RR=1.15,95%CI 0.93 to 1.42,P=0.20).And there were significant differences between retrobular injection of glucocorticoid alone and retrobular injection of glucocorticoid combined with radiotheraphy in the effective rate(RR=0.85,95%CI 0.72 to 1.00,P=0.04).Three patients of the ROGC experienced intraorbital hemorrhage and two of the ROGC experienced aggravation of soft tissues.There were no systemic adverse reactions such as weight gaining and Cushing's syndrome.Conclusion Retrobular injection of glucocorticoid appears to be an effective treatment for thyroid-associated ophthalmopathy.And combination retrobular injection of glucocorticoid with radiotheraphy seems to be more effective.
出处 《中国循证医学杂志》 CSCD 2010年第6期678-682,共5页 Chinese Journal of Evidence-based Medicine
关键词 甲状腺相关眼病 球后注射治疗 糖皮质激素 META分析 Thyroid-associated ophthalmopathy Retrobular injection Glucocorticoid Meta-analysis
  • 相关文献

参考文献10

二级参考文献42

  • 1顾锋,白耀,郭芝生,戴为信,吕朝,杜源耀.环孢素A治疗重症Graves眼病的临床观察[J].中华内分泌代谢杂志,1996,12(4):242-243. 被引量:16
  • 2陈敏,周翔天,盛文,瞿佳.甲状腺相关性眼病研究治疗新进展[J].国际眼科杂志,2006,6(4):875-878. 被引量:23
  • 3[1]Perros P, Kendall-Taylor P. Antibodies to orbital tissues in thyroid -associated ophthalmopathy [ J ]. Acta Endocroinol (copenh), 1992, 126(2): 137 ~ 42. 被引量:1
  • 4[3]刘新氏.实用内分泌学[M].人民军医出版社,1997,71. 被引量:1
  • 5杨华胜.甲状腺相关眼病[A].吴中耀.现代眼肿瘤眼眶病学[C].北京:人民军医出版社,2002.464--500. 被引量:5
  • 6Hadj Ali I, Khiari K, Cherif L, et al. Treatment of Graves' disease: 300 cases[J].Presse Med,2004,33(1):17-21. 被引量:1
  • 7Bromberg N, Romaldini JH, Werner RS,et al. The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine[J].J Endocrinol Invest,1992,15(3):191-195. 被引量:1
  • 8Wiersinga WM. Preventing Graves' ophthalmopathy[J].N Engl J Med, 1998,338(2):121-122. 被引量:1
  • 9Harsch I, Paschke R, Usadel KH. The possible etiological role of psychological disturbances in Graves' disease[J].Acta Med Austriaca,1992,19(1):62-65. 被引量:1
  • 10Chang TC, Huang KM, Hsiao YL, et al. Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy[J].Acta Ophthalmol Scand,1997,75(3):301-304. 被引量:1

共引文献36

同被引文献73

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部